Novel method to select meaningful outcomes for evaluation in clinical trials

被引:4
|
作者
McLeod, Charlie [1 ,2 ]
Norman, Richard [3 ]
Wood, Jamie [4 ,5 ]
Mulrennan, Siobhain [6 ,7 ]
Morey, Sue [6 ]
Schultz, Andre [8 ,9 ]
Messer, Mitch [10 ]
Spaapen, Kate [11 ]
Stoneham, Matthew [12 ]
Wu, Yue [13 ]
Smyth, Alan [14 ]
Blyth, Christopher [1 ,10 ]
Webb, Steve [15 ,16 ]
Mascaro, Steven [17 ]
Woodberry, Owen [17 ]
Snelling, Tom [13 ,18 ]
机构
[1] Perth Childrens Hosp, Infect Dis, Nedlands, WA, Australia
[2] Telethon Kids Inst, Infect Dis Implementat Res, Nedlands, WA, Australia
[3] Curtin Univ, Sch Populat Hlth, Bentley Campus, Bentley, WA, Australia
[4] Icahn Sch Med Mt Sinai, Abil Res Ctr, Dept Rehabil & Human Performance, New York, NY 10029 USA
[5] Sir Charles Gairdner Hosp, Dept Physiotherapy, Nedlands, WA, Australia
[6] Sir Charles Gairdner Hosp, Resp Med, Nedlands, WA, Australia
[7] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA, Australia
[8] Telethon Kids Inst, Wal Yan Resp Res Ctr, Nedlands, WA, Australia
[9] Perth Childrens Hosp, Dept Resp Med, Nedlands, WA, Australia
[10] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia
[11] Consumer Advocate, Perth, WA, Australia
[12] Consumer Advocate, Melbourne, Vic, Australia
[13] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia
[14] Univ Nottingham, Sch Med, Evidence Based Child Hlth Grp, Nottingham, England
[15] Monash Univ, Sch Populat Hlth & Prevent Med, Clayton, Vic, Australia
[16] St John God Hlth Care, Dept Intens Care Med, Perth, WA, Australia
[17] Bayesian Intelligence, Upwey, Vic, Australia
[18] Menzies Sch Hlth Res, Casuarina, NT, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
cystic fibrosis; paediatric lung disaese; rare lung diseases; respiratory infection; SURROGATE END-POINTS;
D O I
10.1136/bmjresp-2021-000877
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A standardised framework for selecting outcomes for evaluation in trials has been proposed by the Core Outcome Measures in Effectiveness Trials working group. However, this method does not specify how to ensure that the outcomes that are selected are causally related to the disease and the health intervention being studied. Causal network diagrams may help researchers identify outcomes that are both clinically meaningful and likely to be causally dependent on the intervention, and endpoints that are, in turn, causally dependent on those outcomes. We aimed to (1) develop a generalisable method for selecting outcomes and endpoints in trials and (2) apply this method to select outcomes for evaluation in a trial investigating treatment strategies for pulmonary exacerbations of cystic fibrosis (CF). Methods We conducted a series of online surveys and workshops among people affected by CF. We used a modified Delphi approach to develop a consensus list of important outcomes. A workshop involving domain experts elicited how these outcomes were causally related to the underlying pathophysiological processes. Meaningful outcomes were prioritised based on the extent to which each outcome captured separate rather than common aspects of the underlying pathophysiological process. Results The 10 prioritised outcomes were: breathing difficulty/pain, sputum production/clearance, fatigue, appetite, pain (not related to breathing), motivation/demoralisation, fevers/night sweats, treatment burden, inability to meet personal goals and avoidance of gastrointestinal symptoms. Conclusions This proposed method for selecting meaningful outcomes for evaluation in clinical trials may improve the value of research as a basis for clinical decisions.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Translating Clinical Trials into Meaningful Outcomes
    LoRusso, Patricia M.
    Schnipper, Lowell E.
    Stewart, David J.
    Boerner, Scott A.
    Averbuch, Steven D.
    Wolf, Walter
    CLINICAL CANCER RESEARCH, 2010, 16 (24) : 5951 - 5955
  • [2] An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials
    Kumar, Hemanth
    Fojo, Tito
    Mailankody, Sham
    JAMA ONCOLOGY, 2016, 2 (09) : 1238 - 1240
  • [3] CLINICAL TRIALS IN SEPSIS: BETTER DESIGN, MORE MEANINGFUL OUTCOMES
    Hough, Catherine L.
    SHOCK, 2019, 51 (06): : 11 - 11
  • [4] Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
    Green, Michael F.
    Schooler, Nina R.
    Kern, Robert S.
    Frese, Fred J.
    Granberry, Wendy
    Harvey, Philip D.
    Karson, Craig N.
    Peters, Nancy R. N.
    Stewart, Michelle
    Seidman, Larry J.
    Sonnenberg, John
    Stone, William S.
    Walling, David
    Stover, Ellen
    Marder, Stephen R.
    AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (04): : 400 - 407
  • [5] The long march to surrogates of meaningful clinical outcomes in MS trials Are we there yet?
    Wolinsky, J. S.
    Beck, C. A.
    NEUROLOGY, 2011, 77 (18) : 1658 - 1659
  • [6] Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials A Systematic Review
    Rahib, Lola
    Fleshman, Julie M.
    Matrisian, Lynn M.
    Berlin, Jordan D.
    JAMA ONCOLOGY, 2016, 2 (09) : 1209 - 1216
  • [7] Is restenosis a meaningful outcome in clinical trials?
    Spertus, J
    Poston, WSC
    Jones, P
    AMERICAN HEART JOURNAL, 2002, 144 (05) : 894 - 895
  • [8] American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
    Ellis, Lee M.
    Bernstein, David S.
    Voest, Emile E.
    Berlin, Jordan D.
    Sargent, Daniel
    Cortazar, Patricia
    Garrett-Mayer, Elizabeth
    Herbst, Roy S.
    Lilenbaum, Rogerio C.
    Sima, Camelia
    Venook, Alan P.
    Gonen, Mithat
    Schilsky, Richard L.
    Meropol, Neal J.
    Schnipper, Lowell E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1277 - +
  • [9] How researchers should select the best outcomes for randomised clinical trials in paediatric dentistry?
    Mendes, Fausto M.
    Braga, Mariana M.
    Passaro, Ana Laura
    Moro, Bruna L. P.
    Freitas, Raiza Dias
    Gimenez, Thais
    Tedesco, Tamara K.
    Raggio, Daniela P.
    Pannuti, Claudio M.
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2020, 31 : 23 - 30
  • [10] EVALUATION OF THE USE OF SURROGATE OUTCOMES IN ONCOLOGY CLINICAL TRIALS
    Sharma, R.
    Goulding, R.
    Franklin, M.
    VALUE IN HEALTH, 2022, 25 (07) : S333 - S333